Skip to content
The Policy VaultThe Policy Vault

biologic immunomodulator agentsBlue Cross Blue Shield of Oklahoma

non-radiographic axial spondyloarthritis (nr-axSpA)

Initial criteria

  • Has tried and had inadequate response to TWO different NSAIDs after at least a 4-week total duration OR
  • Has inadequate response to ONE NSAID after ≥4 weeks and intolerance/hypersensitivity to another OR
  • Intolerance/hypersensitivity to TWO NSAIDs OR
  • FDA labeled contraindication to ALL NSAIDs